Apellis Pharmaceuticals Inc (APLS) — Free Cash Flow Generation Index

Latest as of September 2025: 1.00x

Apellis Pharmaceuticals Inc (APLS) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $108.32 Million represents 1% of operating cash flow ($108.47 Million). Read Apellis Pharmaceuticals Inc (APLS) total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

$108.32 Million

USD

Operating Cash Flow

$108.47 Million

USD

Capital Expenditures

$148.00K

USD

Apellis Pharmaceuticals Inc Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for Apellis Pharmaceuticals Inc across 1 annual periods. Explore APLS capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Apellis Pharmaceuticals Inc (2025–2025)

Year-by-year Free Cash Flow Generation Index for Apellis Pharmaceuticals Inc. For the full company profile including market capitalisation, see Apellis Pharmaceuticals Inc market capitalisation.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2025	0.99x	$45.01 Million	$45.33 Million	$313.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).